These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 343894)

  • 1. New drugs in hypertension.
    Myers MG
    Can Med Assoc J; 1977 Jan; 116(2):173-6. PubMed ID: 343894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mechanisms of action of some antihypertensive drugs.
    Laverty R
    Br Med Bull; 1973 May; 29(2):152-7. PubMed ID: 4356551
    [No Abstract]   [Full Text] [Related]  

  • 3. Letter: Debrisoquine, guanethidine, and bethanidine in hypertension.
    Talbot S; O'Malley BC; Bing RH
    Br Med J; 1975 May; 2(5965):278. PubMed ID: 1131592
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical pharmacology of antihypertensive drugs.
    Nies AS
    Med Clin North Am; 1977 May; 61(3):675-98. PubMed ID: 16188
    [No Abstract]   [Full Text] [Related]  

  • 5. Antihypertensive activity of erythro-1-(1-[2-(1,4-benzodioxan-2-yl)-2-OH-ET]-4-piperidyl)-2-benzimidazolinone (R 28935).
    Wellens D; Snoeckx L; De Reese R; Kruger R; Van de Water A; Woutens L; Reneman RS
    Arch Int Pharmacodyn Ther; 1975 May; 215(1):119-32. PubMed ID: 1156041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Centrally acting sympathetic inhibitors for therapy of patients with hypertension].
    Kawasaki H
    Nihon Rinsho; 1997 Aug; 55(8):2081-5. PubMed ID: 9284427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of antihypertensive therapy on sympathetic nervous system activity in patients with essential hypertension.
    Chernow B; Zaloga GP; Lake CR; Coleman MD; Ziegler MG
    Fed Proc; 1984 Jan; 43(1):72-7. PubMed ID: 6317467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renin and the therapy of hypertension.
    Guthrie GP; Genest J; Kuchel O
    Annu Rev Pharmacol Toxicol; 1976; 16():287-308. PubMed ID: 779617
    [No Abstract]   [Full Text] [Related]  

  • 9. Factors predisposing to postural hypotensive symptoms in the treatment of high blood pressure.
    Talbot S; Smith AJ
    Br Heart J; 1975 Oct; 37(10):1059-63. PubMed ID: 127594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychiatric side effects of antihypertensive drugs other than reserpine.
    Paykel ES; Fleminger R; Watson JP
    J Clin Psychopharmacol; 1982 Feb; 2(1):14-39. PubMed ID: 6121825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Withdrawal syndromes and the cessation of antihypertensive therapy.
    Hart GR; Anderson RJ
    Arch Intern Med; 1981 Aug; 141(9):1125-7. PubMed ID: 6114720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complications of antihypertensive therapy.
    Shapiro AP; Traub YM
    Am Fam Physician; 1981 Mar; 23(3):155-63. PubMed ID: 7468405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antihypertensive effects of a new transdermal delivery system for clonidine in genetic and experimental hypertensive rats.
    Ishii R; Tagawa T; Ishida T; Naruse T
    Arzneimittelforschung; 1996 Mar; 46(3):261-8. PubMed ID: 8901146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Role of the adrenal medulla in the effect of antihypertensive drugs].
    Montastruc JL; Rostin M; Lhoste F; Gaillard-Plaza G; Montastruc P
    Arch Mal Coeur Vaiss; 1985 Oct; 78(11):1647-51. PubMed ID: 3938235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the central and peripheral components for induction of postural hypotension by guanethidine, clonidine, dopamine2 receptor agonists and 5-hydroxytryptamine1A receptor agonists.
    Park KH; Long JP; Cannon JG
    J Pharmacol Exp Ther; 1991 Dec; 259(3):1221-30. PubMed ID: 1762069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation by practicing physicians of the antihypertensive efficacy of debrisoquin, methyldopa and propranolol].
    Avigdor L; Waeber B; Brunner HR
    Schweiz Med Wochenschr; 1983 Mar; 113(9):331-8. PubMed ID: 6342133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin-converting enzyme inhibitors in hypertension: a review.
    Salvetti A; Pedrinelli R; Arzilli F; Abdel-Haq B; Magagna A; Lucarini A; Graziadei L; Nuccorini A; Taddei S
    Int J Clin Pharmacol Res; 1985; 5(6):429-38. PubMed ID: 3005182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Current antihypertensive drugs: mechanism of action].
    Perrier CV; Sitavanc L
    Schweiz Med Wochenschr; 1973 Nov; 103(47):1678-86. PubMed ID: 4150373
    [No Abstract]   [Full Text] [Related]  

  • 19. General pharmacology of the novel centrally acting antihypertensive agent moxonidine.
    Armah BI; Hofferber E; Stenzel W
    Arzneimittelforschung; 1988 Oct; 38(10):1426-34. PubMed ID: 3196383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of severe hypertension with nifedipine in combination with clonidine or propranolol.
    Imai Y; Abe K; Otsuka Y; Irokawa N; Yasujima M; Saito K; Sakurai Y; Chiba S; Ito T; Sato M; Haruyama T; Miura Y; Yoshinaga K
    Arzneimittelforschung; 1980; 30(4):674-8. PubMed ID: 6994751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.